Skip to content

Xylem

US · XYL #827 by market cap Listed 1970
94.66 -0.58 -0.61%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:33

Price chart

Pre-market 96.00 +0.80%
After-hours 94.66 0.00%
Overnight 95.25 +0.01%
124.8288.2394.662026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on XYL?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -23.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 3.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 21.0x Better than 40%
Forward P/E 20.0x Better than 36%
Price / Sales 2.4x Better than 51%
P/E vs own 5-yr range 1st pctl Better than 99%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 17.8% Better than 80%
Net income CAGR (3Y) 39.2% Better than 85%
Free cash flow CAGR (3Y) 32.9% Better than 76%
Profitability B-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 38.5% Better than 46%
Operating margin 14.7% Better than 64%
Net margin 10.6% Better than 61%
Return on equity 8.7% Better than 47%
Return on invested capital 7.3% Better than 57%
Momentum C-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -16.2% Better than 37%
6-month return -13.5% Better than 34%
12-month return (ex latest month) -21.1% Better than 14%
Distance below 52-week high 34.7% Better than 35%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 46%
Debt to assets 11.7% Better than 67%
Interest coverage 41.7x Better than 89%
Free cash flow / net income 95.1% Better than 35%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 50.0% Better than 26%
Upside to average target 24.7% Better than 41%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +0.51%
1M -9.86%
3M -16.24%
6M -11.85%
YTD -29.71%
1Y -30.47%
3Y -2.28%
5Y -21.98%

Key statistics

Price & volume

Prev close
95.24
Open
96.00
Day range
94.19 - 97.57
Avg price
95.18
Volume
3.00M
Turnover
285.54M
Amplitude
3.55%
52-week range
87.40 - 144.93

Valuation

P/E
24.15
P/E (TTM)
20.99
P/B
2.11
EPS
3.92
Net profit
898.99M
Net assets
10.27B

Share structure

Market cap
21.71B
Float cap
21.64B
Shares out
229.33M
Float shares
228.61M

Dividend & listing

Dividend (TTM)
1.69
Listing date
1970-01-01
52-week range 13% of range
87.40 144.93

34.7% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-125.05M net over the window

Short interest

Shares short
8.66M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Xylem (XYL)?

Xylem last traded at 94.66. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Xylem's market cap?

About 21.71B.

What is the P/E ratio of Xylem?

The trailing twelve-month P/E is 20.99, below its own 5-year average of 40.73 — toward the bottom of its historical range (0.64% percentile). See the Valuation tab for the full history.

Does Xylem pay a dividend?

Yes. The trailing dividend yield is 1.79%. The 2025 payout was up 11.1% from 2024. See the Dividends tab for the full payment history.

Is Xylem a buy according to analysts?

The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 118.08, which implies 24.7% upside from the current price. This is not investment advice.

What is Xylem's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Xylem a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 19:33:55 · For reference only, not investment advice and not tailored to your situation.

Xylem discussion 0 comments

Add a comment